BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1372515)

  • 1. Interaction of a substance P agonist and of substance P antagonists with lipid membranes. A thermodynamic analysis.
    Seelig A
    Biochemistry; 1992 Mar; 31(11):2897-904. PubMed ID: 1372515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P and antagonists. Surface activity and molecular shapes.
    Seelig A
    Biochim Biophys Acta; 1990 Nov; 1030(1):111-8. PubMed ID: 1702320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution conformation of Substance P antagonists-[D-Arg1, D-Trp7,9, Leu11]-SP, [D-Arg1, D-Pro2, D-Trp7,9, Leu11]-SP and [D-Pro2, D-Trp7,9]-SP by CD, NMR and MD simulations.
    Prabhu A; Malde A; Coutinho E; Srivastava S
    Peptides; 2005 May; 26(5):875-85. PubMed ID: 15808918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of slow excitatory post-synaptic potential by substance P antagonists in guinea-pig sympathetic ganglia.
    Konishi S; Otsuka M
    J Physiol; 1985 Apr; 361():115-30. PubMed ID: 2580973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the substance P antagonist, (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine.
    Mandahl A; Bill A
    Acta Physiol Scand; 1984 Jan; 120(1):27-35. PubMed ID: 6202097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
    Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of substance P antagonists with substance P receptors on dispersed pancreatic acini.
    Jensen RT; Jones SW; Lu YA; Xu JC; Folkers K; Gardner JD
    Biochim Biophys Acta; 1984 Jun; 804(2):181-91. PubMed ID: 6202326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of substance P agonists to lipid membranes and to the neurokinin-1 receptor.
    Seelig A; Alt T; Lotz S; Hölzemann G
    Biochemistry; 1996 Apr; 35(14):4365-74. PubMed ID: 8605185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.
    Featherstone RL; Fosbraey P; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):73-7. PubMed ID: 2420402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.
    Woll PJ; Rozengurt E
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1859-63. PubMed ID: 2450349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ability of various substance P antagonists to inhibit action of bombesin.
    Jensen RT; Heinz-Erian P; Mantey S; Jones SW; Gardner JD
    Am J Physiol; 1988 Jun; 254(6 Pt 1):G883-90. PubMed ID: 2454035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of substance P antagonists on the atropine-sensitive and atropine-resistant responses of guinea-pig ileum to substance P.
    Chahl LA
    Neurosci Lett; 1985 Mar; 55(1):35-40. PubMed ID: 2581187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations on the actions of substance P and [D-Arg1,D-Pro2,D-Trp7,9,Leu11)substance P on single neurons of the guinea pig submucous plexus.
    Surprenant A; North RA; Katayama Y
    Neuroscience; 1987 Jan; 20(1):189-99. PubMed ID: 2436087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octyl-beta-D-glucopyranoside partitioning into lipid bilayers: thermodynamics of binding and structural changes of the bilayer.
    Wenk MR; Alt T; Seelig A; Seelig J
    Biophys J; 1997 Apr; 72(4):1719-31. PubMed ID: 9083676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of substance P analogues on spinal dorsal horn neurons.
    Randic M; Jeftinija S; Urban L; Raspantini C; Folkers K
    Peptides; 1988; 9(3):651-60. PubMed ID: 2458574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis.
    Ziegler A; Blatter XL; Seelig A; Seelig J
    Biochemistry; 2003 Aug; 42(30):9185-94. PubMed ID: 12885253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists of substance P from emphasis on position 11.
    Folkers K; Rosell S; Xu JC; Björkroth U; Lu YA; Liu YZ
    Acta Chem Scand B; 1983; 37(7):623-7. PubMed ID: 6197831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1,D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8]-substance P (6-11) characterized by high-performance liquid chromatography.
    Cummings J; MacLellan A; Langdon SP; Smyth JF
    J Pharm Biomed Anal; 1994 Jun; 12(6):811-9. PubMed ID: 7522585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In the eye (D-Pro2, D-Trp7,9)-SP is a substance P agonist, which modifies the responses to substance P, prostaglandin E1 and antidromic trigeminal nerve stimulation.
    Mandahl A; Bill A
    Acta Physiol Scand; 1983 Jan; 117(1):139-44. PubMed ID: 6190353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide binding to lipid bilayers. Binding isotherms and zeta-potential of a cyclic somatostatin analogue.
    Beschiaschvili G; Seelig J
    Biochemistry; 1990 Dec; 29(49):10995-1000. PubMed ID: 2271694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.